In the LEAD-5 trial, liraglutide (1.8 mg once daily) reduced HbA1c more than insulin glargine during the treatment period (26 weeks) [31]
Why weight comes back Weight regain is not a willpower failure
Dosing Phases, Titration & Cycling Unlike short recovery peptides, semaglutide is not run in on/off cycles. The documented protocol is a single continuous escalation to a maintenance dose that is then held, because the metabolic effect depends on sustained receptor engagement weight tends to return when the drug is stopped
It is designed for people who want to support gut barrier integrity and general gut health rather than specifically targeting GLP-1 production
3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%